Events, News

Home → News & Events → Events

More than research: TETRIS meets Amazona Stockholm and the People behind Patient Support

On 7 October 2026, one day before the start of the 3rd TETRIS General Assembly in Stockholm, representatives of the TETRIS consortium visited Bröstcancerföreningen Amazona Stockholm, Sweden’s largest breast cancer patient association, for an afternoon dedicated to learning, sharing experiences and strengthening collaboration.

The visit brought together project partners from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (INT), Vall d’Hebron Institute of Oncology (VHIO), Università Vita-Salute San Raffaele (UniSR), Karolinska University Hospital and Cuore di Donna, the Italian Association also part of the Patient Association Board, offering an opportunity to learn more about the association, its activities and its commitment to supporting people affected by breast cancer.

A place where no one faces breast cancer alone

Amazona’s work is guided by the vision that no one should suffer from breast cancer. Its mission is to ensure that everyone has the right to the best available breast cancer care, with a promise that lies at the heart of everything the association does “No one should be alone with their breast cancer.”

During the afternoon, accompanied by a traditional Swedish fika (Swedish coffee break with something sweet) members of Amazona introduced the TETRIS delegation to the many activities carried out by the association.

These include supporting patients in hospitals, organising activities and meetings at the association’s premises, and reaching out to communities across Stockholm, including people from minority and migrant backgrounds who may face language, cultural or social barriers when accessing healthcare and support.

What Amazona is making with people lied on the reason that many of its members have experienced breast cancer themselves and this shared experience creates an environment in which people diagnosed with the disease can find understanding, reassurance and a sense of belonging. Over time, they come to feel that they are surrounded by close friends rather than people they have met simply because they share the same diagnosis.

Listening to experiences beyond clinical care

The discussions also highlighted the complex personal and social challenges that can accompany a breast cancer diagnosis. Amzona shared several stories: young women facing cancer before having had children, and the particular emotional and practical challenges this can bring, women from different cultural backgrounds, including situations where religious beliefs, misinformation or cultural expectations may influence decisions about treatment and many more.

These stories offered a powerful reminder that breast cancer care extends beyond diagnosis and medical treatment and TETRIS partners had the opportunity to listen directly to people with lived experience of breast cancer and reflect on the importance of patient-centred communication, accessibility and inclusion in research and healthcare.

For researchers, clinicians and all people in general, understanding patients’ circumstances, fears, expectations and cultural backgrounds is essential to providing meaningful support and ensuring that no one is left behind.

From patient support to European research: REBECCA and MELIORA

The afternoon concluded with presentations of two European research projects in which Amazona has been actively involved as a project partner, demonstrating how patient associations can contribute directly to research and innovation:

  • REBECCA – REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data
  • MELIORA – Multimodal Engagement and sustainable Lifestyle Interventions Optimizing breast cancer Risk reduction supported by Artificial Intelligence

The first one, funded under the European Union’s Horizon 2020 programme, aiming to improve post-treatment care and quality of life for people affected by breast cancer, has been recently concluded. For more info, click here REBECCA Project.

The second one, it’s an Horizon 2024–2027 with the aim to reduce the risk of developing or experiencing a recurrence of breast cancer by promoting sustainable lifestyle changes through AI-supported tools. Info on the project, here MELIORA Project

The visit to Amazona has been particularly meaningful and reinforced the value of bringing patient perspectives into research, ensuring that scientific and technological developments remain connected to the needs of the people they are intended to benefit.

A special thank you goes to Bröstcancerföreningen Amazona Stockholm and all its members who welcomed the TETRIS delegation, shared their experiences and introduced us to the association’s work.

Their openness, dedication and commitment to supporting people affected by breast cancer made this visit an important moment of learning and exchange for the entire group.

We left Amazona with a deeper understanding of the value of listening, supporting and involving patients and a renewed commitment to keeping their voices at the centre of TETRIS.

Thank you!

To learn more about Amazona and its activities, visit the website: www.amazona.se

Newsletter

Subscribe to our newsletter to stay up to date on the latest news, receive updates and invitations to events.

Follow Us

@projectetris
⏳ Calling all researchers in radiation oncology! 
The deadline to submit your abstract for ESTRO 2027 is approaching! 

An important opportunity to share your research, present scientific advances and connect with the international radiation oncology community. 

📅 Abstract submission deadline: 11 November 2026 
🔗 Submit your abstract: https://bit.ly/4zvNufW 

#ESTRO2027 #TETRISproject #RadiationOncology #Radiotherapy #CancerResearch #ScientificResearch #HorizonEurope

1 0
🇸🇪 The 3rd TETRIS General Assembly has successfully concluded in Stockholm!

On 8-9 October, the TETRIS consortium gathered at the Karolinska Comprehensive Cancer Centre, hosted by our partner Karolinska University Hospital, for two days of scientific exchange, collaboration and discussions on the project's progress and next steps. Fondazione IRCCS Istituto Nazionale dei Tumori  @istituto_tumori Vall d’Hebron Institute of Oncology - VHIO  @vhiobarcelona @polimi @unisr  @gmxenomica  @AQUILAB by Coexya @Neolys Diagnostics

The meeting brought together consortium partners, Scientific Advisory Board members, Professor Alfons Hoekstra and Professor Carolyn Taylor, and patient representatives, Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, providing an important opportunity to share results, exchange perspectives and strengthen collaboration across the different areas of research. @bcfamazona @brostcancerforeningen_amazona @associazione_cuoredidonna @Associazione Cuore di Donna

💡 Many key takeaways emerged from these two days, from making better use of existing clinical data to advance personalised risk prediction and exploring the potential of Digital Twins, to strengthening patient involvement and translating scientific advances into meaningful improvements in post-treatment care.

The General Assembly also featured educational sessions on AI in radiotherapy and Male breast cancer, broadcast from Stockholm and delivered by Maria Carmen De Santis from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, as well as valuable contributions from our Scientific and Patient Advisory Boards.

👏 Our sincere thanks to Karolinska University Hospital for hosting the meeting, to our Scientific Advisors, Patient Representatives and all project partners for their active participation and contributions.

👉 Read the full news and discover the highlights and key outcomes of our 3rd General Assembly on the TETRIS website: urlr.me/nwQyNT.

#TETRISproject #TETRISGeneralAssembly #BreastCancer #Radiotherapy #DigitalTwins #PersonalisedMedicine #PatientCentredCare #CancerResearch #HorizonEurope

11 0